New: NCI-funded clinical trial search
Mednet Logo

How would you treat a male patient with history of hormone positive HER2 negative pT2N2M0 left breast cancer treated with mastectomy and ddAC chemo in 2022 and now developed a right sided pT1bN0 breast cancer while being on tamoxifen?